Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company